Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

JK AGRI GENETICS 2021-22 Annual Report Analysis
Wed, 24 Aug

JK AGRI GENETICS has announced its results for the year ended March 2022. Let us have a look at the detailed performance review of the company during FY21-22.

JK AGRI GENETICS Income Statement Analysis

  • Operating income during the year rose 9.9% on a year-on-year (YoY) basis.
  • The company's operating profit decreased by 16.6% YoY during the fiscal. Operating profit margins witnessed a fall and stood at 5.6% in FY22 as against 7.3% in FY21.
  • Depreciation charges decreased by 2.6% and finance costs decreased by 13.7% YoY, respectively.
  • Other income grew by 54.5% YoY.
  • Net profit for the year grew by 7.8% YoY.
  • Net profit margins during the year declined from 3.2% in FY21 to 3.1% in FY22.

JK AGRI GENETICS Income Statement 2021-22

No. of Mths Year Ending 12 Mar-21* 12 Mar-22* % Change
Net Sales Rs m 2,238 2,458 9.9%
Other income Rs m 36 56 54.5%
Total Revenues Rs m 2,274 2,515 10.6%
Gross profit Rs m 164 136 -16.6%
Depreciation Rs m 35 34 -2.6%
Interest Rs m 64 56 -13.7%
Profit before tax Rs m 100 103 2.4%
Tax Rs m 28 25 -11.3%
Profit after tax Rs m 72 77 7.8%
Gross profit margin % 7.3 5.6
Effective tax rate % 28.4 24.6
Net profit margin % 3.2 3.1
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Dear Reader: If You Invest in Midcap Stocks, this is for You

JK AGRI GENETICS Balance Sheet Analysis

  • The company's current liabilities during FY22 stood at Rs 2 billion as compared to Rs 2 billion in FY21, thereby witnessing an increase of 14.5%.
  • Long-term debt stood at Rs 139 million as compared to Rs 69 million during FY21, a growth of 102.1%.
  • Current assets rose 16% and stood at Rs 3 billion, while fixed assets fell 10% and stood at Rs 312 million in FY22.
  • Overall, the total assets and liabilities for FY22 stood at Rs 3 billion as against Rs 3 billion during FY21, thereby witnessing a growth of 13%.

JK AGRI GENETICS Balance Sheet as on March 2022

No. of Mths Year Ending 12 Mar-21* 12 Mar-22* % Change
Networth Rs m 1,354 1,420 4.9
 
Current Liabilities Rs m 1,629 1,866 14.5
Long-term Debt Rs m 69 139 102.1
Total Liabilities Rs m 2,923 3,292 12.7
 
Current assets Rs m 2,578 2,981 15.6
Fixed Assets Rs m 345 312 -9.6
Total Assets Rs m 2,923 3,292 12.7
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



JK AGRI GENETICS Cash Flow Statement Analysis

  • JK AGRI GENETICS's cash flow from operating activities (CFO) during FY22 stood at Rs -9 million on a YoY basis.
  • Cash flow from investing activities (CFI) during FY22 stood at Rs 54 million on a YoY basis.
  • Cash flow from financial activities (CFF) during FY22 stood at Rs -5 million, an improvement of 86% on a YoY basis.
  • Overall, net cash flows for the company during FY22 stood at Rs 40 million from the Rs -50 million net cash flows seen during FY21.

JK AGRI GENETICS Cash Flow Statement 2021-22

Particulars No. of months 12 12 % Change
Year Ending Mar-21 Mar-22
Cash Flow from Operating Activities Rs m 214 -9 -
Cash Flow from Investing Activities Rs m -224 54 -
Cash Flow from Financing Activities Rs m -40 -5 -
Net Cash Flow Rs m -50 40 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for JK AGRI GENETICS

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 16.7, an improvement from the EPS of Rs 15.5 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 501.5, stands at -74.9 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 1.6 times, while the price to sales ratio stands at 0.9 times.
  • The company's price to cash flow (P/CF) ratio stood at 31.6 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-21* 12 Mar-22*
Sales per share (Unadj.) Rs 482.3 529.8
TTM Earnings per share Rs 15.5 16.7
Diluted earnings per share Rs 15.5 16.7
Price to Cash Flow x 23.3 31.6
TTM P/E ratio x 34.7 -74.9
Price / Book Value ratio x 2.2 2.5
Market Cap Rs m 2,989 3,528
Dividends per share (Unadj.) Rs 1.5 1.5
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for JK AGRI GENETICS

  • Solvency Ratios
  • Current Ratio: The company's current ratio improved and stood at 1.6x during FY22, from 1.6x during FY21. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio improved and stood at 2.8x during FY22, from 2.6x during FY21. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company improved and stood at 5.4% during FY22, from 5.3% during FY22. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company declined and down at 10.1% during FY22, from 11.6% during FY21. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company declined and down at 4.0% during FY22, from 4.7% during FY21. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-21* 12 Mar-22*
Current ratio x 1.6 1.6
Debtors’ Days Days 1,254 1,537
Interest coverage x 2.6 2.8
Debt to equity ratio x 0.1 0.1
Return on assets % 4.7 4.0
Return on equity % 5.3 5.4
Return on capital employed % 11.6 10.1
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how JK AGRI GENETICS has performed over the last 5 years, please visit here.

JK AGRI GENETICS Share Price Performance

Over the last one year, JK AGRI GENETICS share price has moved down from Rs 712.5 to Rs 501.5, registering a loss of Rs 211.0 or around 29.6%.

Overall, the S&P BSE SENSEX is up 6.4% over the year.

(To know more, check out historical annual results for JK AGRI GENETICS and quarterly results for JK AGRI GENETICS)

Annual Report FAQs

What is the current share price of JK AGRI GENETICS?

JK AGRI GENETICS currently trades at Rs 479.0 per share. You can check out the latest share price performance of JK AGRI GENETICS here...

What was the revenue of JK AGRI GENETICS in FY22? How does it compare to earlier years?

The revenues of JK AGRI GENETICS stood at Rs 2,515 m in FY22, which was up 10.6% compared to Rs 2,274 m reported in FY21.

JK AGRI GENETICS' revenue has grown from Rs 2,050 m in FY18 to Rs 2,515 m in FY22.

Over the past 5 years, the revenue of JK AGRI GENETICS has grown at a CAGR of 5.2%.

What was the net profit of JK AGRI GENETICS in FY22? How does it compare to earlier years?

The net profit of JK AGRI GENETICS stood at Rs 77 m in FY22, which was up 7.8% compared to Rs 72 m reported in FY21.

This compares to a net loss of Rs -108 m in FY20 and a net profit of Rs 50 m in FY19.

Over the past 5 years, JK AGRI GENETICS net profit has grown at a CAGR of -10.4%.

What does the cash flow statement of JK AGRI GENETICS reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of JK AGRI GENETICS reveals:

  • Cash flow from operations decreased in FY22 and stood at Rs -9 m as compared to Rs 214 m in FY21.
  • Cash flow from investments increased in FY22 and stood at Rs 54 m as compared to Rs -224 m in FY21.
  • Cash flow from financial activity increased in FY22 and stood at Rs -5 m as compared to Rs -40 m in FY21.

Here's the cash flow statement of JK AGRI GENETICS for the past 5 years.

(Rs m)FY18FY19FY20FY21FY22
From Operations-423253214-9
From Investments-10-15-22454
From Financial Activity8-2014-40-5
Net Cashflow-62272-5040

What does the Key Ratio analysis of JK AGRI GENETICS reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of JK AGRI GENETICS reveals:

  • Operating profit margins witnessed a fall and stood at 5.6% in FY22 as against 7.3% in FY21.
  • Net profit margins declined from 3.2% in FY21 to 3.1% in FY22.
  • Debt to Equity ratio for FY22 stood at 0.1 as compared to 0.1 in FY21.

Here's the ratio/financial analysis of JK AGRI GENETICS for the past 5 years.

 FY18FY19FY20FY21FY22
Operating Profit Margin (%)12.28.8-2.47.35.6
Net Profit Margin (%)5.92.6-6.03.23.1
Debt to Equity Ratio (x)0.00.20.10.10.1

Equitymaster requests your view! Post a comment on "JK AGRI GENETICS 2021-22 Annual Report Analysis". Click here!